Russell Investments Group Ltd. Cuts Stake in InfuSystem Holdings, Inc. (NYSE:INFU)

Russell Investments Group Ltd. lowered its stake in InfuSystem Holdings, Inc. (NYSE:INFU - Free Report) by 13.8% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 387,014 shares of the company's stock after selling 62,109 shares during the quarter. Russell Investments Group Ltd. owned 1.82% of InfuSystem worth $3,270,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in INFU. BNP Paribas Financial Markets lifted its stake in shares of InfuSystem by 66.4% in the 3rd quarter. BNP Paribas Financial Markets now owns 4,076 shares of the company's stock worth $27,000 after purchasing an additional 1,626 shares during the period. State Street Corp increased its holdings in InfuSystem by 1.1% during the third quarter. State Street Corp now owns 267,012 shares of the company's stock valued at $1,789,000 after buying an additional 3,019 shares during the last quarter. Barclays PLC boosted its stake in shares of InfuSystem by 300.5% during the 3rd quarter. Barclays PLC now owns 28,597 shares of the company's stock worth $192,000 after acquiring an additional 21,457 shares during the last quarter. Geode Capital Management LLC boosted its stake in shares of InfuSystem by 1.8% during the 3rd quarter. Geode Capital Management LLC now owns 436,508 shares of the company's stock worth $2,925,000 after acquiring an additional 7,550 shares during the last quarter. Finally, JPMorgan Chase & Co. grew its position in shares of InfuSystem by 74.1% during the 3rd quarter. JPMorgan Chase & Co. now owns 15,556 shares of the company's stock valued at $104,000 after acquiring an additional 6,623 shares during the period. 71.13% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on the company. Sidoti upgraded InfuSystem to a "strong-buy" rating in a research report on Tuesday, March 18th. StockNews.com upgraded InfuSystem from a "buy" rating to a "strong-buy" rating in a research note on Friday, March 14th.

InfuSystem Price Performance

Shares of INFU traded down $0.11 during trading hours on Tuesday, reaching $4.80. 357,918 shares of the stock traded hands, compared to its average volume of 84,796. InfuSystem Holdings, Inc. has a 52-week low of $4.61 and a 52-week high of $9.97. The company has a current ratio of 1.98, a quick ratio of 1.59 and a debt-to-equity ratio of 0.50. The company has a market cap of $100.88 million, a P/E ratio of 80.01 and a beta of 1.90. The company's 50-day moving average price is $6.05 and its two-hundred day moving average price is $7.33.

About InfuSystem

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.